Check out the companies making headlines after the bell:
Shares of Workday seesawed in extended trading on Tuesday — jumping as much as 2% before falling more than 1% — after the software company reported better-than-expected first-quarter earnings. The company reported earnings of 43 cents per share on revenue of $825 million. Wall Street had expected earnings of 41 cents per share on revenue of $814 million, according to Refinitiv consensus estimates. The company also gave strong guidance for the second-quarter and the current fiscal year.
Inovio Pharmaceuticals stock plummeted as much as 11% after news broke that Astrazeneca, a pharmaceutical company, will discontinue its research collaborations with the biotech company.
Heico stock surged more than 8% after the aerospace company reported second-quarter earnings that pleased investors. Heico reported earnings of 60 cents per share and net sales of $515.6 million. Refinitiv consensus estimates had projected earnings of 49 cents per share and net sales of $479.5 million.
Shares of Soliton surged nearly 20% after the medical device company announced it received clearance from the FDA to market its tattoo-removal device, the Rapid Acoustic Pulse. The device removes black ink tattoos from the arms, legs and torsos of some people.
